Ronan Swords, Devalingam Mahalingam, Swaminathan Padmanabhan, Jennifer Carew, & Francis Giles. (2009). Nilotinib: Optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib. Dove Medical Press.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Ronan Swords, Devalingam Mahalingam, Swaminathan Padmanabhan, Jennifer Carew, و Francis Giles. Nilotinib: Optimal Therapy for Patients with Chronic Myeloid Leukemia and Resistance or Intolerance to Imatinib. Dove Medical Press, 2009.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Ronan Swords, et al. Nilotinib: Optimal Therapy for Patients with Chronic Myeloid Leukemia and Resistance or Intolerance to Imatinib. Dove Medical Press, 2009.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.